New publications
Aspirin reduces risk of liver cancer, but dangerous for the stomach
Last reviewed: 01.07.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
A new study by American scientists suggests that long-term use of aspirin is associated with a reduced risk of hepatocellular carcinoma, a common type of primary liver cancer, and a reduced risk of death from chronic liver disease.
Scientists from the National Cancer Institute in the United States conducted a long-term study involving more than 300,000 women and men aged 50 to 71. The volunteers were monitored for twelve years.
As it turned out, people who took aspirin at least once a month were 49% less likely to develop liver cancer and 50% less likely to die from chronic liver disease over the next twelve years compared to those who did not take aspirin.
The miraculous power of aspirin has been proven by experts not for the first time. Scientists have already found out that taking aspirin reduces the risk of stroke and heart attack, and also reduces the risk of developing malignant tumors. Now aspirin has another miraculous property.
"There is growing evidence that taking aspirin may protect against and prevent the development of some types of cancer in the long term," the researchers comment.
However, despite such positive results, scientists are still in no hurry to elevate aspirin to the ranks of drugs recommended for disease prevention. As is known, aspirin is very dangerous for the stomach, in particular, it significantly increases the risk of internal bleeding in the gastrointestinal tract. That is why the use of aspirin as a means of preventing cardiovascular diseases raises great doubts and is still in question.
For the prevention of liver diseases and cancer, the best prevention, no matter how you look at it, is a healthy lifestyle. Moreover, it is not recommended to rely on aspirin for those who already have liver problems. A side effect of such a drug is gastric bleeding, and patients with a diseased liver are predisposed to it.
[